You are Here : Moneycontrol Forum Forum Topics Stocks

Sun Pharma

Diana Horton
Gold Member

1983 Messages

Approval for the company s novel treatment for the skin condition psoriasis has been delayed, Shanghvi said on a call with analysts and investors on Tuesday. It s now expected either at the end of 2018 or in 2019, he said. This won t have an impact on the medicine getting permission from the U.S. regulator and Sun Pharma still sees its introduction next year in that market, Shanghvi said.

12.58 AM Nov 15th
I agree to the M3 code of conduct


Get your own permanent - nickname

Choose your nickname

Your permanent Nickname can be distinct from your username and no one need know the link between the two.

Follow us on
Available On